Immune Response to High-Dose vs. Standard Dose Influenza Vaccine
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 11 Jul 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2018.
- 14 Jul 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.
- 14 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.